BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 2018
View Archived Issues
Positive outcome from European decentralized procedure for Ferring's Testavan
Read More
Elthera generates preclinical proof-of-concept data with anti-L1CAM antibodies
Read More
EMA accepts type II variation application for Xtandi in non-metastatic CRPC
Read More
TissueGene changes name to Kolon TissueGene
Read More
Japan Tobacco and Rohto sign exclusive Japanese license agreement for JTE-052
Read More
eTheRNA completes low-dose cohort enrollment in phase Ib study of ECI-006 for melanoma
Read More
BMS-986166: a partial agonist of S1P1 with reduced pulmonary and cardiovascular toxicity
Read More
Bavarian Nordic partners with U.S. DoD to develop equine encephalitis virus vaccine
Read More
[225Ac]-PSMA radioligand therapy safe and effective in mCRPC patients
Read More
Valneva releases phase I interim data on Lyme vaccine candidate VLA-15
Read More
MicroRNA 520a is a potential prognostic biomarker of hepatocellular carcinoma
Read More
Novel HBV-replication inhibitors discovered at Gilead
Read More
Rutherrin shown to destroy human brain cancer stem cells
Read More
Lycera patents new Rho-associated protein kinase 1/2 inhibitors
Read More
Novel IDO-1 inhibitors presented by Bristol-Myers Squibb
Read More
Institute of Radiation Medicine presents novel compounds protecting against radiation
Read More
Sunshine Lake Pharma describes new influenza A virus H1N1 inhibitors
Read More
Mereo announces topline phase IIb results for BGS-649 to treat hypogonadotropic hypogonadism
Read More
Advaxis initiates phase I study of ADXS-NEO in solid tumors
Read More
Crinetics Pharmaceuticals' CRN-00808 shows promise in phase I acromegaly trial
Read More
Phase I data reported for intravesical VPM-1002BC in non-muscle invasive bladder cancer
Read More